(Q45880265)

English

Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases.

scientific article published in October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

colon carcinoma

1 reference

based on heuristic

inferred from title

Mario Paolo Colombo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Antonella Stoppacciaro

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C Chiodoni

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Sangaletti

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

B Cappetti

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Y Koezuka

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

European Journal of Immunology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

3101-3110

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Immune suppression and skin cancer development: regulation by NKT cells.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Interferon gamma-independent rejection of interleukin 12-transduced carcinoma cells requires CD4+ T cells and Granulocyte/Macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Interleukin-12: role of interferon-gamma in IL-12 adverse effects

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

NKT cells are phenotypically and functionally diverse

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Experimental model for liver metastasis formation using Lewis lung tumor

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8

21 January 2018

Identifiers

10.1002/1521-4141(2001010)31:10<3101::AID-IMMU3101>3.0.CO;2-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

release_upux3fcidbgafjzgjwtkydjbxq

1 reference

https://api.fatcat.wiki/v0/release/upux3fcidbgafjzgjwtkydjbxq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45880265&oldid=1837141613"